Medicare Enrolled

Dr. Jessica Surloff

Medical Physician Assistant · Springfield, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
385 MORRIS AVE, Springfield, NJ 07081
9733792111
In practice since 2008 (18 years)
NPI: 1609044957 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Surloff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Surloff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Surloff

Dr. Jessica Surloff is a medical physician assistant in Springfield, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Surloff performed 99 Medicare services across 66 unique beneficiaries.

Between the years covered by Open Payments, Dr. Surloff received a total of $4,722 from 51 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Surloff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 99 Medicare services $4,722 industry payments

Medicare Practice Summary

Medicare Utilization ↗
99
Medicare services
Bottom 24% in NJ for medical physician assistant
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
66
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
70 $57 $240
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
29 $1 $10
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,722
Total received (2021-2024)
Avg $1,180/year across 4 years
Top 8% in NJ for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
203
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,231 (68.4%)
Other
Charitable contributions, space rental, and other categories
$1,127 (23.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$364 (7.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,151
2023
$1,256
2022
$1,258
2021
$1,057

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Exelixis Inc.
$293
Novartis Pharmaceuticals Corporation
$211
PFIZER INC.
$139
Incyte Corporation
$119
Mirati Therapeutics, Inc.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$60
Amgen Inc.
$45
ABBVIE INC.
$42
Celgene Corporation
$32
Daiichi Sankyo Inc.
$31
BeiGene USA, Inc.
$27
GlaxoSmithKline, LLC.
$19
Astellas Pharma US Inc
$16
Genentech USA, Inc.
$15
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 55.9% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$1,243
Exelixis Inc.
$504
EMD Serono, Inc.
$239
PFIZER INC.
$231
Mirati Therapeutics, Inc.
$215
Incyte Corporation
$203
ABBVIE INC.
$170
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Seagen Inc.
$164
Amgen Inc.
$135
Takeda Pharmaceuticals U.S.A., Inc.
$113
Janssen Biotech, Inc.
$106
Daiichi Sankyo Inc.
$95
E.R. Squibb & Sons, L.L.C.
$88
Bayer HealthCare Pharmaceuticals Inc.
$70
GlaxoSmithKline, LLC.
$67
Genentech USA, Inc.
$59
BeiGene USA, Inc.
$55
Rigel Pharmaceuticals, Inc.
$49
Regeneron Healthcare Solutions, Inc.
$45
Celgene Corporation
$44
Merck Sharp & Dohme LLC
$39
TAIHO ONCOLOGY, INC.
$36
AstraZeneca Pharmaceuticals LP
$34
Sumitomo Pharma America, Inc.
$32
Astellas Pharma US Inc
$32
GENZYME CORPORATION
$31
Lilly USA, LLC
$30
CTI BioPharma Corp.
$30
MorphoSys, US Inc.
$30
Taiho Oncology, Inc.
$29
Blueprint Medicines Corporation
$28
Merck Sharp & Dohme Corporation
$28
Janssen Pharmaceuticals, Inc
$25
Emmaus Medical, Inc.
$23
Spectrum Pharmaceuticals Inc.
$20
ARRAY BIOPHARMA INC
$19
PUMA BIOTECHNOLOGY, INC.
$18
Global Blood Therapeutics, Inc.
$17
Pharmacosmos Therapeutics Inc.
$17
JAZZ PHARMACEUTICALS INC.
$15
Ipsen Biopharmaceuticals, Inc
$15
Alexion Pharmaceuticals, Inc.
$15
TG Therapeutics, Inc.
$15
Welch Allyn
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Pharmacyclics LLC, an AbbVie Company
$13
EISAI INC.
$13
Baxter Healthcare
$13
Acceleron Pharma, Inc.
$11
Clovis Oncology, Inc.
$3
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Columvi · DARZALEX · ELIQUIS · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · FRUZAQLA · Fabhalta · IBRANCE · IMBRUVICA · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · None · Nubeqa · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · Phesgo · REBLOZYL · ROLVEDON · Reblozyl · Rubraca · SCEMBLIX · SOMATULINE DEPOT · Stivarga · TASIGNA · TUKYSA · Tavalisse · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · Vonjo · XARELTO · Xospata · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for medical physician assistant in NJ.

Looking for a medical physician assistant in Springfield?
Compare medical physician assistants in the Springfield area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants within 10 mi
1,594
Per 100K population
278.4
County median income
$100,117
Nearest hospital
OVERLOOK MEDICAL CENTER
2.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Surloff is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Surloff experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Surloff performed 70 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Surloff receive payments from pharmaceutical companies?
Yes. Dr. Surloff received a total of $4,722 from 51 companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Surloff's costs compare to other medical physician assistants in Springfield?
Dr. Surloff's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Surloff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →